Cargando…
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome
Malignant mesothelioma is a deadly tumor whose diagnosis and treatment remain very challenging. There is an urgent need to advance our understanding of mesothelioma biology and to identify new molecular markers for improving management of patients. CD157 is a membrane glycoprotein linked to ovarian...
Autores principales: | Ortolan, Erika, Giacomino, Alice, Martinetto, Francesca, Morone, Simona, Lo Buono, Nicola, Ferrero, Enza, Scagliotti, Giorgio, Novello, Silvia, Orecchia, Sara, Ruffini, Enrico, Rapa, Ida, Righi, Luisella, Volante, Marco, Funaro, Ada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171622/ https://www.ncbi.nlm.nih.gov/pubmed/25026285 |
Ejemplares similares
-
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma
por: Augeri, Stefania, et al.
Publicado: (2018) -
Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition
por: Napoli, Francesca, et al.
Publicado: (2022) -
Correction to: Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition
por: Napoli, Francesca, et al.
Publicado: (2022) -
Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma
por: Napoli, Francesca, et al.
Publicado: (2021) -
Overexpression of CD157 Contributes to Epithelial Ovarian Cancer Progression by Promoting Mesenchymal Differentiation
por: Morone, Simona, et al.
Publicado: (2012)